Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell Hayes

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Breast Cancer Research and Treatment|December 3, 2013
Patient preferences regarding intraoperative versus external beam radiotherapy following breast-conserving surgeryMichael D Alvarado, Jay Conolly, Catherine Park, et al.
Cancer Control : Journal of the Moffitt Cancer Center|January 23, 2025
Short- and Intermediate-Term Morbidity Following Total Pelvic Exenteration in Colorectal CancerChristopher Guske, Nusheen Immen, Devon Conant, et al.
Plos Pathogens|April 15, 2024
Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in miceJillian A Bristol, Scott E Nelson, Makoto Ohashi, et al.
Plos Pathogens|April 26, 2022
Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cellsJillian A Bristol, Joshua Brand, Makoto Ohashi, et al.
Plos Pathogens|June 17, 2020
EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized miceChunrong Li, James C Romero-Masters, Shane Huebner, et al.
Plos Pathogens|July 28, 2018
A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infectionJillian A Bristol, Reza Djavadian, Emily R Albright, et al.
Journal of Virology|March 6, 2020
An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse ModelJames C Romero-Masters, Makoto Ohashi, Reza Djavadian, et al.
Minerva Urology and Nephrology|May 20, 2026
Survival outcomes after cytoreductive nephrectomy with tumor thrombectomy: results from the Intercontinental Collaboration on Renal Cell CarcinomaMaxwell Sandberg, Gregory Russell, Phillip Krol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2022
Stress Keratin 17 Expression in Head and Neck Cancer Contributes to Immune Evasion and Resistance to Immune-Checkpoint BlockadeWei Wang, Taja Lozar, Athena E Golfinos, et al.
Plos Pathogens|October 3, 2022
Type 1 and Type 2 Epstein-Barr viruses induce proliferation, and inhibit differentiation, in infected telomerase-immortalized normal oral keratinocytesDeo R Singh, Scott E Nelson, Abigail S Pawelski, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Breast Cancer Research and Treatment|December 3, 2013
Patient preferences regarding intraoperative versus external beam radiotherapy following breast-conserving surgeryMichael D Alvarado, Jay Conolly, Catherine Park, et al.
Cancer Control : Journal of the Moffitt Cancer Center|January 23, 2025
Short- and Intermediate-Term Morbidity Following Total Pelvic Exenteration in Colorectal CancerChristopher Guske, Nusheen Immen, Devon Conant, et al.
Plos Pathogens|April 15, 2024
Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in miceJillian A Bristol, Scott E Nelson, Makoto Ohashi, et al.
Plos Pathogens|April 26, 2022
Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cellsJillian A Bristol, Joshua Brand, Makoto Ohashi, et al.
Plos Pathogens|June 17, 2020
EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized miceChunrong Li, James C Romero-Masters, Shane Huebner, et al.
Plos Pathogens|July 28, 2018
A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infectionJillian A Bristol, Reza Djavadian, Emily R Albright, et al.
Journal of Virology|March 6, 2020
An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse ModelJames C Romero-Masters, Makoto Ohashi, Reza Djavadian, et al.
Minerva Urology and Nephrology|May 20, 2026
Survival outcomes after cytoreductive nephrectomy with tumor thrombectomy: results from the Intercontinental Collaboration on Renal Cell CarcinomaMaxwell Sandberg, Gregory Russell, Phillip Krol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2022
Stress Keratin 17 Expression in Head and Neck Cancer Contributes to Immune Evasion and Resistance to Immune-Checkpoint BlockadeWei Wang, Taja Lozar, Athena E Golfinos, et al.
Plos Pathogens|October 3, 2022
Type 1 and Type 2 Epstein-Barr viruses induce proliferation, and inhibit differentiation, in infected telomerase-immortalized normal oral keratinocytesDeo R Singh, Scott E Nelson, Abigail S Pawelski, et al.
Pageof 4